Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prophylactic intracoronary adenosine in non-ST-elevation myocardial infarction
IRCT20170619034621N2Phase 2Completed
- Sponsor
- Rajaie Cardiovascular Medical and Research Center
- Start
- Nov 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of adenosine in Non-ST-segment elevation myocardial infarction (NSTEMI), sponsored by Rajaie Cardiovascular Medical and Research Center. Started Nov 2019; status: completed.
02
Drugs
adenosine
03
Conditions
Non-ST-segment elevation myocardial infarction (NSTEMI)
Beyond the preview
Go deeper on IRCT20170619034621N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20170619034621N2.